A recent study suggests that patients who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop conventional lifestyle regimens.
Research printed in a major health publication points out that while obese people frequently drop a large proportion of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"People purchasing these treatments should be informed of the risk of rapid rebound weight gain when the therapy concludes," stated expert Dr. Susan Jebb.
This pace of regain implies a return to starting mass in about 18 months.
Analyzing Approaches
The research, which reviewed 37 of studies involving over 9,000 of participants, contrasted the results of these new drugs with conventional dieting.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone usually have a less rapid creep back—approximately 0.1 kg a month—post-intervention.
Explaining the Fast Rebound
Doctors propose the way of the injections is key to understanding the accelerated regain.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of the hormone levels far above than normal could lead to the system to produce less of its endogenous hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
Health authorities recommend the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Many experts argue that, considering the likelihood of weight regain, the therapy might need to be long-term.
This perspective is supported by drug manufacturers, who say that the findings "highlight the long-term character of excess weight," akin to managing diseases like diabetes.
User Testimonies
Users who have come off the medication explain a powerful return of hunger.
"I experienced a switch flipping and you're instantly ravenous," said an individual.
The struggle is worsened if users have not established permanent dietary or behavioural modifications during therapy.
Widespread Adoption
Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is higher among females compared to men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Finally, researchers emphasize that while these medications are powerful tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on combined lifestyle support.
